Advertisement

Topics

Effect of Adding Cetuximab vs Bevacizumab to Chemotherapy for KRAS Wild-Type Colorectal Cancer

20:00 EDT 19 Jun 2017 | JAMA

This randomized clinical trial compares the effect of adding bevacizumab vs cetuximab to standard chemotherapy regimens on overall survival among patients with advanced or metastatic KRAS wild-type colorectal cancer.

Original Article: Effect of Adding Cetuximab vs Bevacizumab to Chemotherapy for KRAS Wild-Type Colorectal Cancer

NEXT ARTICLE

More From BioPortfolio on "Effect of Adding Cetuximab vs Bevacizumab to Chemotherapy for KRAS Wild-Type Colorectal Cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...